Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Gastroenterology

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/J.GASTRO.2006.02.020PMID 16618420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiostatin

  2004cited by this paper
• Metastasis and angiogenesis.

  2004cited by this paper
• Endothelial Cell Surface ATP Synthase-Triggered Caspase-Apoptotic Pathway Is Essential for K1-5-Induced Antiangiogenesis

  2004cited by this paper
• Antiangiogenic property of pigment epithelium‐derived factor in hepatocellular carcinoma

  2004cited by this paper
• Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene

  2003cited by this paper
• Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1–5

  2003cited by this paper
• Kringle structures and antiangiogenesis.

  2002cited by this paper
• Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis

  2002cited by this paper
• Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice

  2001cited by this paper
• Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

  2001cited by this paper
• Specific Interaction of Angiostatin with Integrin αvβ3 in Endothelial Cells*

  2001cited by this paper
• Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats.

  2000cited by this paper
• Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.

  2000cited by this paper
• Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis

  2000cited by this paper
• New directions in liposome gene delivery

  1999cited by this paper
• Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings.

  1999cited by this paper
• Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.

  1999cited by this paper
• Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

  1999cited by this paper
• Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice.

  1999cited by this paper
• Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.

  1998cited by this paper
• Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells

  1998cited by this paper
• Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.

  1998cited by this paper
• A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

  1998cited by this paper
• Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell Growth*

  1997cited by this paper
• Improved DNA: liposome complexes for increased systemic delivery and gene expression

  1997cited by this paper
• Angiostatin induces and sustains dormancy of human primary tumors in mice

  1996cited by this paper
• Blood vessel formation: what is its molecular basis?

  1996cited by this paper
• Kringle Domains of Human Angiostatin

  1996cited by this paper
• Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

  1995cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.

  1991cited by this paper
• NIH conference. Hepatocellular carcinoma.

  1988cited by this paper

• Targeting angiogenic genes as a therapeutic approach for hepatocellular carcinoma.

  2015cites this paper
• Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.

  2014cites this paper
• Isolation and purification of recombinant human plasminogen Kringle 5 by liquid chromatography and ammonium sulfate salting-out.

  2014cites this paper
• Evaluation of the Antiangiogenic Effect of Kringle 1-5 in a Rat Glioma Model

  2012cites this paper
• E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma

  2011cites this paper
• Gene therapy of liver cancer: an update

  2011cites this paper
• A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

  2010cites this paper
• Methods and Applications of Hepatoxicity and Hepatoprotective Assays

  2009cites this paper
• Clinical significance of α‐fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma

  2008cites this paper
• Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-B Combination Gene Therapy Prolongs Angiogenic Effects via Recruitment of Interstitial Mononuclear Cells and Paracrine Effects Rather Than Improved Pericyte Coverage of Angiogenic Vessels

  2008cites this paper
• Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro‐angiogenic and prometastatic factors in murine liver fibrosis

  2008cites this paper
• E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases

  2008cites this paper
• Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor.

  2007cites this paper